What You Should Know:
- Digital surgery pioneer Activ Surgical raises $15M in funding led by ARTIS Ventures to accelerate U.S. commercialization and European expansion efforts for its ActiveEdge platform, which enables existing surgical systems, from scopes to robots, to visualize, characterize and track tissue, in real-time beyond today’s human capability.
- ActivSight, is an easy-to-adapt, connected imaging module that seamlessly attaches to today’s laparoscopic and arthroscopic
Read More
Cancer | Digital Health Impact on Cancer Care | Policy, News, Analysis, Insights - HIT Consultant
Paige Lands Additional $20M for AI-Native Digital Pathology Ecosystem
What You Should Know:
- Paige secures an additional $15M from Goldman Sachs totaling $20M to close out a total Series B funding round of $70M for its AI-native digital pathology ecosystem.
- The company’s continued product portfolio of innovation in telepathology and digital diagnostics accelerated by further investment.
Paige, an NYC-based leader in computational pathology transforming the diagnosis and treatment of cancer, today announced it received an additional $15M from
Read More
Philips and BioIntelliSense Integrate to Enhance Remote Patient Monitoring
What You Should Know:
- Philips integrates the BioIntelliSense FDA-cleared
BioSticker™ sensor as part of its remote patient monitoring solutions for
patients outside the hospital.
- Multi-parameter sensors aid monitoring across multiple chronic conditions with medical-grade vital signs for physicians to remotely track core symptoms, including COVID-19.
- Healthcare Highways is the first to leverage the BioSticker sensor as a part of Philips’ RPM program in the U.S.
Philips,
Read More
Cedar Nabs $102M to Modernize Patient Financial Experience
What You Should Know:
- Cedar raises $102M to fuel the next phase of Cedar’s vision of evolving from a patient financial engagement solution to a comprehensive healthcare consumer engagement platform.
- Cedar combines healthcare, tech, and design to create a seamless financial experience for every patient. From pre-visit registration to post-visit billing, Cedar personalizes the care journey to take each patient to payment with ease.
- The company also announced it has partnered with
Read More
NYC Hospitals Leverage Taxi App to Transport Frontline Health Workers, Patients During COVID-19
What You Should Know:
- Curb, a taxi platform that connects two-thirds of the city’s
yellow and green taxis, has partnered with organizations like NY Langone,
Mount Sinai, American Cancer Society, and the NYC Department of Health &
Mental Hygiene to provide frontline workers with a safe alternative to public
transit and rideshares like Uber.
- Launched during the pandemic, the partnership has enabled Curb to power more
than 100,000 taxi rides for doctors,
Read More
MD Anderson, Philips Partner on Personalized Oncology Treatments, Clinical Trial Matching
What You Should Know:
- Philips and MD Anderson collaborate to facilitate
personalized oncology treatments and clinical trial matching based on genomic
markers.
- Philips connects oncologists and pathologists around
the world to MD Anderson’s Precision Oncology Decision Support (PODS) system of
actionable clinical information
Philips and The University of Texas MD Anderson Cancer
Center today announced a collaboration to provide oncologists with
evidence-based therapy and clinical
Read More
FCC Surpasses $100M in Approved COVID-19 Telehealth Program Applications
What You Should Know:
- FCC’s COVID-19 Telehealth Program, which was authorized by the CARES Act, has approved funding for 305 healthcare providers in 42 states plus Washington, D.C. for a total of $105M in funding.
The Federal Communications
Commission’s Wireline Competition Bureau today approved an additional 67 funding applications
for the COVID-19 Telehealth Program. Healthcare
providers in both urban and rural areas of the country will use this $16.87M in
funding to
Read More
Consumer Genetic Tests Accelerate Precision Medicine for Some Providers
Direct-to-consumer (DTC) genetic tests have been on the scene for some time now. The Federal Drug Administration (FDA) approved the first DTC test on three specific BRCA1/BRCA2 breast cancer gene mutations more than two years ago. Six months after that, the agency similarly green-lighted a DTC pharmacogenomic (PGx) test to examine 33 variants for eight different genes that indicate how effectively patients metabolize specific medications.
Like many such advances, availability of DTC tests is
Read More
Sharecare Acquires Evidence-Based Behavior Change Apps MindSciences
What You Should Know:
- Sharecare announced the acquisition of Boston-based MindSciences, an evidence-based behavior change suite of apps focused on mental health (anxiety, stress management), smoking cessation, and weight loss/binge eating, and more.
- The acquisition rounds out Sharecare’s portfolio of mHealth-based therapeutic programs improving chronic disease risk and overall health outcomes by targeting varying aspects of well-being.
- Based on the work of Dr. Judson Brewer, now
Read More
Oncologists Believe Social Determinants of Health Impacts Outcomes for Cancer Patients
What You Should Know:
- Oncologists state social determinants of health (SDOH) significantly impact outcomes for cancer patients, according to new research from Cardinal Health Specialty Solutions.
- The findings illustrate certain disconnects between physician perceptions and the increasing body of evidence on the significance of SDOH.
- Appropriately, 91 percent of respondents agreed or strongly agreed that SDOH directly impact cancer treatment outcomes.
More than 90% of
Read More
